International Patent: RNAI AGENTS TARGETING RETINOL BINDING PROTEIN 4 (RBP4)

GENEVA, Aug. 21 -- CITY THERAPEUTICS, INC. filed a patent application (US2026/014853) for “RNAI AGENTS TARGETING RETINOL BINDING PROTEIN 4 (RBP4)”. With publication no. WO/2026/173945, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....